Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001178913-18-001826)

Filing Details

Accession Number:: 0001178913-18-001826
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-05-31 16:51:10
Reporting Period:: 2018-05-13

Accepted Time:: 2018-05-31 16:51:10
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1606645	Foamix Pharmaceuticals Ltd.	FOMX	Medicinal Chemicals & Botanical Products (2833)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1727864	Stanley Hirsch	C/O Foamix Pharmaceuticals Ltd. 2 Holtzman Street Rehovot L3 7670402		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Ordinary Shares	Acquisiton	2018-05-13	6,224	$5.04	12,672	No	4	X	Direct
Ordinary Shares	Disposition	2018-05-13	6,164	$5.09	6,508	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	X	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Ordinary Shares	Warrants (right to buy)	Disposition	2018-05-13	6,224	$0.00	6,224	$5.04

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2013-05-14	2018-05-13	No	4	X	Direct

Footnotes

On May 13, 2018, warrants held by Mr. Hirsch for the purchase of up to 6,224 ordinary shares of the Issuer for $5.04 per share were automatically exercised on a net-issuance (cashless) basis upon their expiration, in accordance with their terms. This cashless exercise resulted in the Issuer withholding 6,164 of the warrant shares to pay the exercise price and issuing to Mr. Hirsch the remaining 60 shares.